Nuvation Bio Inc. (NUVB)
NYSE: NUVB · IEX Real-Time Price · USD
3.130
+0.130 (4.33%)
Jul 22, 2024, 11:13 AM EDT - Market open
Nuvation Bio Employees
Nuvation Bio had 51 employees as of December 31, 2023. The number of employees decreased by 2 or -3.77% compared to the previous year.
Employees
51
Change (1Y)
-2
Growth (1Y)
-3.77%
Revenue / Employee
n/a
Profits / Employee
-$1,350,353
Market Cap
773.97M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 51 | -2 | -3.77% |
Dec 31, 2022 | 53 | -11 | -17.19% |
Dec 31, 2021 | 64 | 28 | 77.78% |
Dec 31, 2020 | 36 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Phibro Animal Health | 1,920 |
Sage Therapeutics | 487 |
Travere Therapeutics | 380 |
Lexicon Pharmaceuticals | 285 |
Evolus | 273 |
Wave Life Sciences | 268 |
Pliant Therapeutics | 158 |
4D Molecular Therapeutics | 147 |
NUVB News
- 7 weeks ago - Innovent Announces Taletrectinib(ROS1 Inhibitor)Updated Data from Pivotal Phase 2 TRUST-I Study of are Published in the JCO and Orally Presentedat 2024 ASCO Annual Meeting - PRNewsWire
- 7 weeks ago - Innovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib(ROS1 Inhibitor) are Published in the JCO and Reported at 2024 ASCO Annual Meeting - PRNewsWire
- 7 weeks ago - Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual Meeting - Business Wire
- 7 weeks ago - Nuvation Bio to Present at the Jefferies Global Healthcare Conference - Business Wire
- 2 months ago - Nuvation Bio Reports First Quarter 2024 Financial Results and Provides Business Update - Business Wire
- 3 months ago - Nuvation Bio to Present Updated Data on Taletrectinib, a ROS1 inhibitor, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting - Business Wire
- 3 months ago - Nuvation Bio Completes Acquisition of AnHeart Therapeutics - Business Wire
- 4 months ago - Nuvation Bio Announces Appointment of Colleen Sjogren as Chief Commercial Officer - Business Wire